EMA — authorised 22 August 2017
- Marketing authorisation holder: Novartis Europharm Ltd
- Status: approved
🇪🇺 Kisqali in European Union
EMA authorised Kisqali on 22 August 2017
Marketing authorisation
Kisqali in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Kisqali approved in European Union?
Yes. EMA authorised it on 22 August 2017.
Who is the marketing authorisation holder for Kisqali in European Union?
Novartis Europharm Ltd holds the EU marketing authorisation.